4-Chloromethyl-5-methyl-1,3-Dioxole -2-one (DMDO CL) 80841-78-7 93%

Since our inception in 2014, we are into manufacturing of bulk drug Intermediates and served our customers with great quality products along with Active Pharmaceutical Ingredients (APIs) exporting into 10+ countries around the globe. Our core competence is to cater to the ever-changing and evolving requirements of our quality-conscious clients who are looking for manufacturers committed to quality along with timely delivery and competitive prices. We have recently developed many basic and advanced intermediates and APIs at our in-house R & D center to cater to existing and new customers.

Our commitment to quality and customer delight has been a key strength contributing to our growth and success. Our research and development division constantly strives to improve existing processes (within the regulatory framework) for cost reduction, develop new intermediates, and perform custom synthesis as per customer's requirements. The same helped us in building and maintaining a clientele comprising many prominent pharmaceutical companies including, HIKAL Ltd, SOLARA ACTIVE PHARMA SCIENCES LTD, IPCA LABORATORIES LTD RANU, THEMIS MEDICARE LTD (BULK DRUG), Shilpa Medicare Ltd., METRO CHEM API PVT LTD. and many other domestic and multinational customers.